Skip to content

BREAST AND CERVICAL CANCER

According to the World Health Organization, cervical cancer is globally the second most common type of cancer among women and virtually all cases are linked to genital infection with the human papillomavirus (HPV). There were more than 500 000 new cases of cervical cancer and 250 000 deaths from it worldwide in 2005. Cervical cancer can also be prevented through regular screening coupled with treatment. The most common cancer in women is breast cancer, followed by cervical cancer.

Congress passed the Breast and Cervical Cancer Mortality Prevention Act in 1990, directing the Centers for Disease Control and Prevention (CDC) to establish the National Breast and Cervical Cancer Early Detection Program cervical cancer(NBCCEDP), a program to assist low-income, uninsured, and underinsured women in accessing breast and cervical cancer screening and diagnostic services that are free or low-cost.  Since its inception in 1991, NBCCEDP-funded programs have served more than 4.6 million women, provided more than 11.6 million breast and cervical cancer screening examinations, and diagnosed more than 64,718 breast cancers, 3,756 invasive cervical cancers, and 167,169 premalignant cervical lesions.

Tigerlily Foundation is committed to providing life-saving information to the young women we served.  We have partnered with Cervivor to provide information on how to remain educated, empowered, and your best advocate when it comes to your health.

Brought to you in partnership with Cervivor

Screen-Shot-2020-04-03-at-11.34.44-AM

Supported by

Seagen Logo Collaboration_Genmab
1200px-Amgen.svg-1024x264
220110-SANOFI-LOGO-RGB2
hologic